Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial | Nature Medicine
KINERET® (anakinra) Official HCP Website | Dosing Calculator
Kineret Subcutaneous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome - The Lancet Rheumatology
AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Anakinra
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis - ScienceDirect
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results | Nature Medicine
Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry | The Journal of Rheumatology
Anakinra reduces ventilation need, mortality in COVID-19
KINERET Dosage & Rx Info | Uses, Side Effects
Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease: when dosage matters in overcoming secondary therapy resistance - Sofia Ajeganova, Ann De Becker, Rik Schots, 2020
Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study | Clinical Rheumatology
KINERET® (anakinra) Official Website | Using KINERET for NOMID
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society for ...
Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study | Clinical Rheumatology
Higher-dose Anakinra Is Effective in a Case of Medically Refractory Macrophage Activation Syndrome | The Journal of Rheumatology
PulmCrit – High-dose anakinra for COVID-19: The anti-inflammatory trials begin
Frontiers | Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
JCM | Free Full-Text | Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19
Reference ID: 3933625
Arthritis News: Study Finds No Treatment Benefit of Intra-Articular Anakinra in Knee Osteoarthritis
A randomized controlled pilot trial of anakinra for hemodialysis inflammation - Kidney International
Study Backs Cytokine Targeting for COVID-19 Tx | MedPage Today
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review - Charlesworth - European Journal of Haematology - Wiley Online Library
